Author:
Vitry Agnes,Nguyen Tuan,Entwistle Vikky,Roughead Elizabeth
Funder
Australian Research Council (AU)
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Johnson JR, Ning YM, Farrell A, Justice R, Keegan P, Pazdur R. Accelerated approval of oncology products: the food and drug administration experience. J Natl Cancer Inst. 2011;103(8):636–44. doi: 10.1093/jnci/djr062 .
2. Carlson JJ, Sullivan SD, Garrison LP, Neumann PJ, Veenstra DL. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy. 2010;96(3):179–90. doi: 10.1016/j.healthpol.2010.02.005 .
3. U.S. Food and Drug Administration. Drugs@FDA. 2013. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist . Accessed 22 July 2013.
4. Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med. 2007;357(26):2666–76. doi: 10.1056/NEJMoa072113 .
5. Hollis C. Avastin sales growth aided by journal reprints. Drug Industry Daily. 2008.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献